A Clinical Pilot Study of Newly Developed Ostomy Tapes and How They Adhere to the Skin

NCT ID: NCT04544566

Last Updated: 2021-05-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-07-07

Study Completion Date

2020-08-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

An investigation of non-CE marked stoma tape products. This investigation is a randomised, open-label, comparative, cross-over study, with three test periods. In total, 12 subjects will be included and randomised.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The test products are non-CE marked stoma tape products. This investigation is a randomised, open-label, comparative, cross-over study, with three test periods. In total, 12 subjects will be included and randomised.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stoma Site Leakage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test product A new adhesive material

The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.

Group Type EXPERIMENTAL

Test product A

Intervention Type DEVICE

one new adhesive material which is applied to the baseplate and the subjects peristomal skin

Test product B

Intervention Type DEVICE

one new adhesive material which is applied to the baseplate and the subjects peristomal skin

Comparator

Intervention Type DEVICE

Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin

Test product B new adhesion material

The adhesives in the ostomy tapes are developed to make the tape seal to the skin and thereby minimise the risk of leakage episodes. At the same time, the tape should be easy to remove without affecting the skin.

Group Type EXPERIMENTAL

Test product A

Intervention Type DEVICE

one new adhesive material which is applied to the baseplate and the subjects peristomal skin

Test product B

Intervention Type DEVICE

one new adhesive material which is applied to the baseplate and the subjects peristomal skin

Comparator

Intervention Type DEVICE

Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin

Comparator

The comparator product is Brava Elastic tape which is already on the market and will be used within the in-tended use in this clinical investigation.

Group Type ACTIVE_COMPARATOR

Test product A

Intervention Type DEVICE

one new adhesive material which is applied to the baseplate and the subjects peristomal skin

Test product B

Intervention Type DEVICE

one new adhesive material which is applied to the baseplate and the subjects peristomal skin

Comparator

Intervention Type DEVICE

Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test product A

one new adhesive material which is applied to the baseplate and the subjects peristomal skin

Intervention Type DEVICE

Test product B

one new adhesive material which is applied to the baseplate and the subjects peristomal skin

Intervention Type DEVICE

Comparator

Already CE- marked product as a comparator which is applied to the baseplate and the subjects peristomal skin

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has given written informed consent
* Be at least 18 years of age and have full legal capacity
* Have had a stoma for more than ½ year
* Have intact skin on the area used in the study (Assessed by investigator, see Appendix 1).
* Willing to change baseplate every second day or less frequent
* Willing to avoid using Concave baseplate during the study.
* Willing to avoid the use of barrier creams or similar that affect the skin/adhesive interface under the tape.

Exclusion Criteria

* Currently receiving or have within the past 2 months received radio-and/or chemotherapy
* Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet(injection) treatment
* Is pregnant or breastfeeding
* Having dermatological problems in the peristomal area (assessed by investigator)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Coloplast A/S

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tonny Karlsmark, MD

Role: PRINCIPAL_INVESTIGATOR

Bispebjerg hospital, Dermato-Venerologisk afdeling.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bispebjerg hospital

Copenhagen, Copenhagen NV, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP319

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CP376 OCT Exploratory Skin Study
NCT06965140 COMPLETED NA